CCS financial statements and SEC filings
CCS annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $4.12B | – | $147.60M | 10-K |
| 2024-12-31 | $4.40B | – | $333.82M | 10-K |
| 2023-12-31 | $3.69B | – | $259.22M | 10-K |
| 2022-12-31 | $4.51B | – | $525.13M | 10-K |
| 2021-12-31 | $4.22B | – | $498.50M | 10-K |
| 2020-12-31 | $3.16B | – | $206.16M | 10-K |
CCS annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $4.46B | $1.87B | $2.59B | 10-Q |
| 2024-12-31 | $4.53B | $1.91B | $2.62B | 10-K |
| 2023-12-31 | $4.14B | $1.75B | $2.39B | 10-K |
| 2022-12-31 | $3.77B | $1.62B | $2.15B | 10-K |
| 2021-12-31 | $3.50B | $1.73B | $1.76B | 10-K |
| 2020-12-31 | $2.85B | $1.56B | $1.28B | 10-K |
CCS annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $153.08M | -$28.77M | -$233.76M | 10-K |
| 2024-12-31 | $125.69M | -$38.97M | $40.31M | 10-K |
| 2023-12-31 | $41.63M | -$43.32M | $23.86M | 10-K |
| 2022-12-31 | $315.35M | -$20.41M | -$274.83M | 10-K |
| 2021-12-31 | -$201.15M | -$8.91M | $131.79M | 10-K |
| 2020-12-31 | $340.58M | -$9.00M | $7.39M | 10-K |